Fisher Buy Helps Thermo Post 240-Percent Revenue Growth in Q1; R&D Spending, Profits Also Rise | GenomeWeb
NEW YORK (GenomeWeb News) — Thermo Fisher Scientific today said first-quarter revenues increased nearly 240 percent as R&D spending rose 55 percent and profit jumped 200 on combined sales and spending stemming from the merger of Thermo Electron and Fisher Scientific.
 
Total receipts for the three months ended March 31 increased to $2.3 billion from $684.3 million year over year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.